• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: a fully human IgG1k anti-programmed death ligand-1 (PD-L1) monoclonal antibody
Date Designated: 06/23/2025
Orphan Designation: treatment of progressive supranuclear palsy (PSP)
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
ImmunoBrain Checkpoint Inc.
200 E. 61st Street, Suite 38F
New York, New York 10065
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-